|
SYNJ2BP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
5.975700E-04 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
2.219500E-03 |
| Stage1-vs-Stage3 |
9.843700E-02 |
| Stage1-vs-Stage4 |
7.957200E-04 |
| Stage2-vs-Stage3 |
2.623200E-04 |
| Stage2-vs-Stage4 |
4.3872999999639E-06 |
| Stage3-vs-Stage4 |
1.592570E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.7253001511649E-10 |
| Normal-vs-Asian |
9.49240686054509E-14 |
| Caucasian-vs-AfricanAmerican |
4.775200E-01 |
| Caucasian-vs-Asian |
8.149200E-01 |
| AfricanAmerican-vs-Asian |
4.499800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
2.701600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
1.63014046705712E-12 |
| Normal-vs-Age(81-100Yrs) |
5.90929999999545E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.567000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.042200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.262400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.690600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.720600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.923000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.975060E-04 |
| Classical-VS-Follicular |
6.09040000000283E-05 |
| Classical-VS-Other |
1.927210E-01 |
| Classical-VS-Normal |
1.64146474190829E-12 |
| Tall-VS-Follicular |
2.74010003575853E-09 |
| Tall-VS-Other |
8.412600E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
1.495100E-03 |
| Follicular-VS-Normal |
1.90570000002666E-06 |
| Other-VS-Normal |
4.05879999998415E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.34967642301854E-14 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
4.98530000003772E-06 |
|
|
